Endothelial dysfunction and oxidant status in pediatric patients with hemoglobin E-β thalassemia

Pediatric Cardiology

Volumn 29, Issue 1, 2008, Pages 130-135

  Kukongviriyapan, Veerapol ^a   Somparn, Nuntiya ^a   Senggunprai, Laddawan ^a   Prawan, Auemduan ^a   Kukongviriyapan, Upa ^a   Jetsrisuparb, Arunee ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Endothelial dysfunction; Forearm blood flow; Oxidative stress; Thalassemia

Indexed keywords

DEFEROXAMINE; GAMMA GLUTAMYLCYSTEINE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HEMOGLOBIN E; LIGASE; SUPEROXIDE;

ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; FEMALE; FOREARM BLOOD FLOW; HUMAN; MALE; OXIDATIVE STRESS; SCHOOL CHILD;

ADOLESCENT; BETA-THALASSEMIA; CHILD; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; GLUTATHIONE; HEMOGLOBIN E; HUMANS; MALE; OXIDATIVE STRESS; PLETHYSMOGRAPHY;

EID: 38349178679     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-007-9107-x     Document Type: Article

References (29)

1. Aessopos A, Farmakis D, Tsironi M, et al. (2006) Endothelial function and arterial stiffness in sickle-thalassemia patients. Atherosclerosis (in press)
2. Aggeli C, Antoniades C, Cosma C, et al. (2005) Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major. Int J Cardiol 105:80-84
3. Amer J, Fibach E (2005) Chronic oxidative stress reduces the respiratory burst response of neutrophils from beta-thalassaemia patients. Br J Haematol 129:435-441
4. Blum A, Yeganeh S, Peleg A, et al. (2005) Endothelial function in patients with sickle cell anemia during and after sickle cell crises. J Thromb Thrombolysis 19:83-86
5. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. (2004) Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89:1187-1193
6. Bryan NS (2006) Nitrite in nitric oxide biology: Cause or consequence? A systems-based review. Free Radic Biol Med 41:691-701
7. Cai H, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87:840-844
8. Centis F, Tabellini L, Lucarelli G, et al. (2000) The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with beta-thalassemia major. Blood 96:3624-3629
9. Cheung YF, Chan GC, Ha SY (2002) Arterial stiffness and endothelial function in patients with beta-thalassemia major. Circulation 106:2561-2566
10. Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR (2004) Complications of beta-thalassemia major in North America. Blood 104:34-39
11. Deo SS, Merchant SM, Kapadia AC (1994) Elevated polymorphonuclear phagocytic function in thalassemia patients by chemiluminescence. Indian J Pediatr 61:395-399
12. Esposito BP, Breuer W, Sirankapracha P, et al. (2003) Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood 102:2670-2677
13. Gulati R, Bhatia V, Agarwal SS (2000) Early onset of endocrine abnormalities in beta-thalassemia major in a developing country. J Pediatr Endocrinol Metab 13:651-656
14. Hahalis G, Alexopoulos D, Kremastinos DT, Zoumbos NC (2005) Heart failure in beta-thalassemia syndromes: a decade of progress. Am J Med 118:957-967
15. Higashi Y, Sasaki S, Nakagawa K, et al. (2001) Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function. J Am Coll Cardiol 37:863-870
16. Ikemoto Y, Ogino H, Teraguchi M, Kobayashi Y (2005) Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease. Pediatr Cardiol 26:782-786
17. Livrea MA, Tesoriere L, Pintaudi AM, et al. (1996) Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 88:3608-3614
18. Lu SC (1999) Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J 13:1169-1183
19. Rother RP, Bell L, Hillmen P, Gladwin MT (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 293:1653-1662
20. Shinar E, Rachmilewitz EA (1990) Oxidative denaturation of red blood cells in thalassemia. Semin Hematol 27:70-82
21. Somparn N, Kukongviriyapan U, Tassaneeyakul W, et al. (2006) Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients. Eur J Clin Pharmacol (in press)
22. Taniyama Y, Griendling KK (2003) Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42:1075-1081
23. Telfer PT, Prestcott E, Holden S, et al. (2000) Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol 110:971-977
24. Tietze F (1969) Enzymic methods for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal Biochem 27:502-522
25. Verdon CP, Burton BA, Prior RL (1995) Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. Anal Biochem 224:502-508
26. Verma S, Buchanan MR, Anderson TJ (2003) Endothelial function testing as a biomarker of vascular disease. Circulation 108:2054-2059
27. Wasi P, Pootrakul P, Fucharoen S, et al. (1985) Thalassemia in southeast Asia: determination of different degrees of severity of anemia in thalassemia. Ann NY Acad Sci 445:119-126
28. Weatherall DJ (1998) Pathophysiology of thalassaemia. Baillieres Clin Haematol 11:127-146
29. White CC, Viernes H, Krejsa CM, et al. (2003) Fluorescence-based microtiter plate assay for glutamate-cysteine ligase activity. Anal Biochem 318:175-180